Enhanced blood–brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles

References

• Burdo JR, Connor JR. (2003). Brain iron uptake and homeostatic mechanisms: an overview. Biometals 16:63–75.
   PubMed Web of Science ®Google Scholar
• Celia C, Trapasso E, Cosco D, et al. (2009). Turbiscan lab® expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf. B: Biointerfaces 72:155–60.
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Zhai MF, Xie XY, et al. (2017). Apoferritin nanocage for brain targeted doxorubicin delivery. Mol Pharm 14:3087–97.
   PubMed Web of Science ®Google Scholar
• Chu ACY, Tsang SY, Lo EHK, Fung KP. (2001). Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells. Life Sci 70:591–601.
   PubMed Web of Science ®Google Scholar
• Gao H. (2017). Perspectives on dual targeting delivery systems for brain tumors. J Neuroimmune Pharmacol 12:6–16.
   PubMed Web of Science ®Google Scholar
• Gao H. (2016). Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B 6:268–86.
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu XL, Li XR. (2011). Research progress on siRNA delivery with nonviral carriers. Int J Nanomedicine 6:1017–25.
   PubMed Web of Science ®Google Scholar
• Gao H, Pang Z, Jiang X. (2013). Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharm Res 30:2485–98.
   PubMed Web of Science ®Google Scholar
• Gao H, Qian J, Cao S, et al. (2012). Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 33:5115–23.
   PubMed Web of Science ®Google Scholar
• Gao H, Yang Z, Cao S, et al. (2014). Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment. Biomaterials 35:2374–82.
   PubMed Web of Science ®Google Scholar
• Gong W, Wang ZY, Liu N, et al. (2011). Improving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermia. Biol Pharm Bull 34:1058–64.
   PubMed Web of Science ®Google Scholar
• Guerrero-Cázares H, Tzeng SY, Young NP, et al. (2014). Biodegradable polymeric nanoparticles show high efficacy and specificity at DNA delivery to human glioblastoma in vitro and in vivo. ACS Nano 8:5141–53.
   PubMed Web of Science ®Google Scholar
• Hu K, Li J, Shen Y, et al. (2009). Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Control Release 134:55–61.
   PubMed Web of Science ®Google Scholar
• Iwanik MJ, Shaw KV, Ledwith BJ, et al. (1984). Preparation and interaction of a low-density lipoprotein: daunomycin complex with P388 leukemic cells. Cancer Res 44:1206–15.
   PubMed Web of Science ®Google Scholar
• Kang T, Jiang M, Jiang D, et al. (2015). Enhancing glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin/transferrin receptor complex. Mol Pharm 12:2947–61.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81.
   PubMed Web of Science ®Google Scholar
• Lal S, La D, Tanguay JRL, Greenwood JA. (2012). Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment. J Neurosci Res 90:769–81.
   PubMed Web of Science ®Google Scholar
• Li MY, Li ZP, Yang Y, et al. (2016). Thermo-sensitive liposome co-loaded of vincristine and doxorubicin based on their similar physicochemical properties had synergism on tumor treatment. Pharm Res 33:1881–98.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Symonds P, Murray JC, et al. (2005). A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 11:990–5.
   PubMed Web of Science ®Google Scholar
• Mulik RS, Bing C, Ladouceur-wodzak M, et al. (2016). Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound. Biomaterials 83:257–68.
   PubMed Web of Science ®Google Scholar
• Nativo P, Prior IA, Brust M. (2008). Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2:1639–44.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (1999). Vector-mediated drug delivery to the brain. Adv Drug Deliv Rev 36:299–321.
   PubMed Web of Science ®Google Scholar
• Qu J, Zhang L, Chen Z, et al. (2016). Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Drug Deliv 23:3408–16.
   PubMed Web of Science ®Google Scholar
• Ruan S, Xiao W, Hu C, et al. (2017). Ligand-Mediated and Enzyme-Directed Precise Targeting and Retention for the Enhanced Treatment of Glioblastoma. ACS Appl Mater Interfaces 9:20348–60.
   PubMed Web of Science ®Google Scholar
• Ruan S, Yuan M, Zhang L, et al. (2015). Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Biomaterials 37:425–35.
   PubMed Web of Science ®Google Scholar
• Sekerdag E, Lüle S, Bozdağ Pehlivan S, et al. (2017). A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles. J Control Release 261:187–98.
   PubMed Web of Science ®Google Scholar
• Shaw TK, Mandal D, Dey G, et al. (2017). Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor. Drug Deliv 24:346–57.
   PubMed Web of Science ®Google Scholar
• Shinde RL, Devarajan PV. (2017). Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion. Drug Deliv 24:152–61.
   PubMed Web of Science ®Google Scholar
• Symonds P, Murray JC, Hunter AC, et al. (2005). Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis differently. Febs Lett 579:6191–8.
   PubMed Web of Science ®Google Scholar
• Zhang B, Sun XY, Mei H, et al. (2013). LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Biomaterials 34:9171–82.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu T, Yu W, et al. (2018). Ligand size and conformation affect the behavior of nanoparticles coated with in vitro and in vivo protein corona. ACS Appl Mater Interfaces 10:9094–103.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhai MF, Chen ZJ, et al. (2017). Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma. Drug Deliv 24:1045–55.
   PubMed Web of Science ®Google Scholar
• Zhao ZX, Gao SY, Wang JC, et al. (2012). Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine(R15) triblock copolymer for siRNA delivery. Biomaterials 33:6793–807.
   PubMed Web of Science ®Google Scholar
• Zhu WJ, Yang SD, Qu CX, et al. (2017). Low-density lipoprotein-coupled micelles with reduction and ph dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor. Int J Nanomedicine 12:3375–93.
   PubMed Web of Science ®Google Scholar
• Zhu QL, Zhou Y, Guan M, et al. (2014). Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy. Biomaterials 35:5965–76.
   PubMed Web of Science ®Google Scholar